Comparing the efficacy of NSAIDs and paracetamol in children

Paediatric Anaesthesia

Volumn 14, Issue 3, 2004, Pages 201-217

  Anderson, Brian J ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b GREEN LANE HOSPITAL   (New Zealand)

Author keywords

Acetaminophen; Efficacy; Nonsteroidal anti inflammatory drugs; Paracetamol; Pharmacodynamics; Pharmacokinetics; Pharmacometrics

Indexed keywords

BUPIVACAINE; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; LOCAL ANESTHETIC AGENT; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

BLEEDING; CHILD; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DUODENUM INJURY; GASTROINTESTINAL TOXICITY; HUMAN; LIVER INJURY; LIVER TOXICITY; PAIN ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; STOMACH INJURY;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; HUMANS;

EID: 1642277982     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.01138.x     Document Type: Review

References (180)

1. Oermann CM, Sockrider MM, Konstan MW. The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes. Chest 1999; 115: 1053-1058.
2. Konstan MW, Byard PJ, Hoppel CL et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995; 332: 848-854.
3. Konstan MW, Hoppel CL, Chai BL et al. Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects. J Pediatr 1991; 118: 956-964.
4. Scott CS, Retsch-Bogart GZ, Kustra RP et al. The pharmacokinetics of ibuprofen suspension, chewable tablets, and tablets in children with cystic fibrosis. J Pediatr 1999; 134: 58-63.
5. Van Overmeire B, Smets K, Lecoutere D et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674-681.
6. Litalien C, Jacqz-Aigrain E. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol. Paediatr Drugs 2001; 3: 817-858.
7. Brown RD, Kearns GL, Wilson JT. Integrated pharmacokinetic- pharmacodynamic model for acetaminophen, ibuprofen, and placebo antipyresis in children. J Pharmacokinet Biopharm 1998; 26: 559-579.
8. Kauffman RE, Nelson MV. Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr 1992; 121: 969-973.
9. Kelley MT, Walson PD, Edge JH et al. Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther 1992; 52: 181-189.
10. Troconiz IF, Armenteros S, Planelles MV et al. Pharmacokinetic- pharmacodynamic modelling of the antipyretic effect of two oral formulations of ibuprofen. Clin Pharmacokinet 2000; 38: 505-518.
11. Shaffer CL, Gal P, Ransom JL et al. Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus. Crit Care Med 2002; 30: 343-348.
12. Mitchell JA, Akarasereenont P, Thiemermann C et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 1993; 90: 11693-11697.
13. Piletta P, Porchet HC, Dayer P. Central analgesic effect of acetaminophen but not of aspirin. Clin Pharmacol Ther 1991; 49: 350-354.
14. Bjorkman R, Hallman KM, Hedner J et al. Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 1994; 57: 259-264.
15. Bjorkman R. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesthesiol Scand Suppl 1995; 103: 1-44.
16. Bourne HR. Drug receptors & pharmacodynamics. In: Katzung BG, ed. Basic & Clinical Pharmacology. Stamford: Appleton & Lange, 1998: 28.
17. Sheiner L, Tozer T. Clinical pharmacokinetics: The use of plasma concentrations of drugs. In: Melmon K, Morelli H, eds. Clinical Pharmacology: Basic Principles of Therapeutics. New York: Macmillan, 1978: 71-109.
18. Beringer P, Aminimanizani A, Synold T et al. Development of population pharmacokinetic models and optimal sampling times for ibuprofen tablet and suspension formulations in children with cystic fibrosis. Ther Drug Monit 2002; 24: 315-321.
19. Splinter WM, Reid CW, Roberts DJ et al. Reducing pain after inguinal hernia repair in children: caudal anesthesia versus ketorolac tromethamine. Anesthesiology 1997; 87: 542-546.
20. Ryhanen P, Adamski J, Puhakka K et al. Postoperative pain relief in children. A comparison between caudal bupivacaine and intramuscular diclofenac sodium. Anaesthesia 1994; 49: 57-61.
21. Moores MA, Wandless JG, Fell D. Paediatric postoperative analgesia. A comparison of rectal diclofenac with caudal bupivacaine after inguinal herniotomy. Anaesthesia 1990; 45: 156-158.
22. Rolf C, Engstrom B, Beauchard C et al. Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Rheumatology (Oxford) 1999; 38: 564-567.
23. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 1997; 33: 184-213.
24. Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: Part 2 - Clinical use. Paediatr Anaesth 1997; 7: 93-101.
25. Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: Part 1 - Pharmacokinetics. Paediatr Anaesth 1997; 7: 5-11.
26. Gunter JB, Varughese AM, Harrington JF et al. Recovery and complications after tonsillectomy in children: a comparison of ketorolac and morphine. Anesth Analg 1995; 81: 1136-1141.
27. Munro HM, Riegger LQ, Reynolds PI et al. Comparison of the analgesic and emetic properties of ketorolac and morphine for paediatric outpatient strabismus surgery. Br J Anaesth 1994; 72: 624-628.
28. Inturrisi CE, Colburn WA. Application of pharmacokinetic-pharmacodynamic modeling to analgesia. In: Foley KM, Inturrisi CE, eds. Advances in Pain Research and Therapy. Opioid Analgesics in the Management of Clinical Pain. New York: Raven Press, 1986: 441-452.
29. Dahlstrom B, Bolme P, Feychting H et al. Morphine kinetics in children. Clin Pharmacol Ther 1979; 26: 354-365.
30. Maunuksela EL, Kokki H, Bullingham RE. Comparison of intravenous ketorolac with morphine for postoperative pain in children. Clin Pharmacol Ther 1992; 52: 436-443.
31. Maunuksela E-L, Olkkola KT. Nonsteroidal anti-inflammatory drugs in pediatric pain management. In: Schlechter NL, Berde CB, Yaster M, eds. Pain in Infants, Children, and Adolescents. Philadelphia: Lippincott Williams & Wilkins, 2003: 171-80.
32. Watcha MF, Ramirez Ruiz M, White PF et al. Perioperative effects of oral ketorolac and acetaminophen in children undergoing bilateral myringotomy. Can J Anaesth 1992; 39: 649-654.
33. Baer GA, Rorarius MG, Kolehmainen S et al. The effect of paracetamol or diclofenac administered before operation on postoperative pain and behaviour after adenoidectomy in small children. Anaesthesia 1992; 47: 1078-1080.
34. Bennie RE, Boehringer LA, McMahon S et al. Postoperative analgesia with preoperative oral ibuprofen or acetaminophen in children undergoing myringotomy. Paediatr Anaesth 1997; 7: 399-403.
35. Bertin L, Pons G, d'Athis P et al. A randomized, double-blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundam Clin Pharmacol 1996; 10: 387-392.
36. Figueras Nadal C, Garcia de Miguel MJ, Gomez Campdera A et al. Effectiveness and tolerability of ibuprofen-arginine versus paracetamol in children with fever of likely infectious origin. Acta Paediatr 2002; 91: 383-390.
37. Purssell E. Treating fever in children: paracetamol or ibuprofen? Br J Community Nurs 2002; 7: 316-320.
38. Tawalbeh MI, Nawasreh OO, Husban AM. Comparative study of diclofenac sodium and paracetamol for treatment of pain after adenotonsillectomy in children. Saudi Med J 2001; 22: 121-123.
39. Van Esch A, Van Steensel Moll HA, Steyerberg EW et al. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med 1995; 149: 632-637.
40. Walson PD, Galletta G, Braden NJ et al. Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clin Pharmacol Ther 1989; 46: 9-17.
41. Goyal PK, Chandra J, Unnikrishnan G et al. Double blind randomized comparative evaluation of nimesulide and paracetamol as antipyretics. Indian Pediatr 1998; 35: 519-522.
42. Pickering AE, Bridge HS, Nolan J et al. Double-blind, placebo-controlled analgesic study of ibuprofen or rofecoxib in combination with paracetamol for tonsillectomy in children. Br J Anaesth 2002; 88: 72-77.
43. Johnson GH, Van Wagoner JD, Brown J et al. Bromfenac sodium, acetaminophen/oxycodone, ibuprofen, and placebo for relief of postoperative pain. Clin Ther 1997; 19: 507-519.
44. Romsing J, Ostergaard D, Senderovitz T et al. Pharmacokinetics of oral diclofenac and acetaminophen in children after surgery. Paediatr Anaesth 2001; 11: 205-213.
45. Anderson BJ, Holford NHG. Rectal paracetamol dosing regimens: determination by computer simulation. Paediatr Anaesth 1997; 7: 451-455.
46. Morton NS, O'Brien K. Analgesic efficacy of paracetamol and diclofenac in children receiving PCA morphine. Br J Anaesth 1999; 82: 715-717.
47. Vetter TR, Heiner EJ. Intravenous ketorolac as an adjuvant to pediatric patient-controlled analgesia with morphine. J Clin Anesth 1994; 6: 110-113.
48. Oztekin S, Hepaguslar H, Kar AA et al. Preemptive diclofenac reduces morphine use after remifentanil-based anaesthesia for tonsillectomy. Paediatr Anaesth 2002; 12: 694-699.
49. Korpela R, Korvenoja P, Meretoja OA. Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology 1999; 91: 442-447.
50. Moore A, Moore O, McQuay H et al. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales. Pain 1997; 69: 311-315.
51. Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: verification from independent data. Pain 1997; 69: 127-130.
52. Moore A, Collins S, Carroll D et al. Single dose paracetamol (acetaminophen), with and without codeine, for postoperative pain. Cochrane Database Syst Rev 2000; 2.
53. Collins SL, Moore RA, McQuay HJ et al. Single dose oral ibuprofen and diclofenac for postoperative pain. Cochrane Database Syst Rev 2002.
54. Prescott LF. Gastrointestinal absorption of drugs. Med Clin North Am 1974; 58: 907-916.
55. Holford NHG. Parametric models of the time course of drug action. In: Van Boxtel CJ, Holford NHG, Danhof M, eds. The In Vivo Study of Drug Action. Amsterdam: Elsevier, 1992: 61-69.
56. Randolph AG, Lacroix J. Randomized clinical trials in pediatric critical care: rarely done but desparately need. Pediatr Crit Care Med 2002; 3: 102-106.
57. Oliveira EJ, Watson DG, Morton NS. A simple microanalytical technique for the determination of paracetamol and its main metabolites in blood spots. J Pharm Biomed Anal 2002; 29: 803-809.
58. Fernhoff PM. Paying for children to participate in research: a slippery slope or an enlightened stairway? J Pediatr 2002; 141: 153-154.
59. Edgar J, Morton NS, Pace NA. Review of ethics in paediatric anaesthesia: intensive care issues. Paediatr Anaesth 2001; 11: 597-601.
60. Edgar J, Morton NS, Pace NA. Review of ethics in paediatric anaesthesia: research issues. Paediatr Anaesth 2001; 11: 473-477.
61. Edgar J, Morton NS, Pace NA. Review of ethics in paediatric anaesthesia: consent issues. Paediatr Anaesth 2001; 11: 355-359.
62. Porter FL, Grunau RE, Anand KJ. Long-term effects of pain in infants. J Dev Behav Pediatr 1999; 20: 253-261.
63. Chauhan RD, Idom CB, Noe HN. Safety of ketorolac in the pediatric population after ureteroneocystostomy. J Urol 2001; 166: 1873-1875.
64. Park JM, Houck CS, Sethna NF et al. Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation. Anesth Analg 2000; 91: 11-15.
65. Gauthier JC, Finley GA, McGrath PJ. Children's self-report of postoperative pain intensity and treatment threshold: determining the adequacy of medication. Clin J Pain 1998; 14: 116-120.
66. Anderson BJ, Woollard GA, Holford NHG. Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy. Eur J Clin Pharmacol 2001; 57: 559-569.
67. Johr M. Postanaesthesia excitation. Paediatr Anaesth 2002; 12: 308-312.
68. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994; 331: 394-398.
69. Chan PL, Holford NH. Drug treatment effects on disease progression. Annu Rev Pharmacol Toxicol 2001; 41: 625-659.
70. Lavy JA. Post-tonsillectomy pain: the difference between younger and older patients. Int J Pediatr Otorhinolaryngol 1997; 42: 11-15.
71. Murthy P, Laing MR. Dissection tonsillectomy: pattern of post-operative pain, medication and resumption of normal activity. J Laryngol Otol 1998; 112: 41-44.
72. Toma AG, Blanshard J, Eynon Lewis N et al. Post-tonsillectomy pain: the first ten days. J Laryngol Otol 1995; 109: 963-964.
73. Beyer JE, Denyes MJ, Villarruel AM. The creation, validation, and continuing development of the Oucher a measure of pain intensity in children. J Pediatr Nurs 1992; 7: 335-346.
74. Bieri D, Reeve RA, Champion GD et al. The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain 1990; 41: 139-1350.
75. Chambers CT, Giesbrecht K, Craig KD et al. A comparison of faces scales for the measurement of pediatric pain: children's and parents' ratings. Pain 1999; 83: 25-35.
76. Beyer JE, McGrath PJ, Berde CB. Discordance between self-report and behavioral pain measures in children aged 3-7 years after surgery. J Pain Symptom Manage 1990; 5: 350-356.
77. Breau LM, Finley GA, McGrath PJ et al. Validation of the non-communicating children's pain checklist-postoperative version. Anesthesiology 2002; 96: 528-535.
78. Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med 2002; 347: 1094-1103.
79. Fitzgerald M, Koltzenburg M. The functional development of descending inhibitory pathways in the dorsolateral funiculus of the newborn rat spinal cord. Brain Res 1986; 389: 261-270.
80. Andrews K, Fitzgerald M. The cutaneous withdrawal reflex in human neonates: sensitization, receptive fields, and the effects of contralateral stimulation. Pain 1994; 56: 95-101.
81. Andrews K, Fitzgerald M. Cutaneous flexion reflex in human neonates: a quantitative study of threshold and stimulus-response characteristics after single and repeated stimuli. Dev Mod Child Neurol 1999; 41: 696-703.
82. Fitzgerald M, Millard C, MacIntosh N. Hyperalgesia in premature infants. Lancet 1988; 1: 292.
83. Sheiner LB. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data. Clin Pharmacol Ther 1994; 56: 309-322.
84. Anderson BJ, Meakin GH. Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth 2002; 12: 205-219.
85. West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997; 276: 122-126.
86. West GB, Brown JH, Enquist BJ. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999; 284: 1677-1679.
87. Anderson BJ, van Lingen RA, Hansen TG et al. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology 2002; 96: 1336-1345.
88. Kauffman RE, Lieh-Lai MW, Uy HG et al. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children. Clin Pharmacol Ther 1999; 65: 382-388.
89. Holford NHG, Peck CC. Population pharmacodynamics and drug development. In: Van Boxtel CJ, Holford NHG, Danhof M, eds. The In Vivo Study of Drug Action. Amsterdam: Elsevier, 1992.
90. Anderson BJ, Monteleone J, Holford NHG. Variability of concentrations after rectal paracetamol. Paediatr Anaesth 1998; 8: 274.
91. Williams DG, Hatch DJ, Howard RF. Codeine phosphate in paediatric medicine. Br J Anaesth 2001; 86: 329-331.
92. Williams DG, Patel A, Howard RF. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth 2002; 89: 839-845.
93. Fisher DM, Birmingham PK, Cote CJ. Rectal acetaminophen pharmacokinetics. Anesthesiology 1998; 88: 1131-1132.
94. Wright PM. Population based pharmacokinetic analysis: why do we need it; what is it; and what has it told us about anaesthetics? Br J Anaesth 1998; 80: 488-501.
95. Whiting B, Kelman AW, Grevel J. Population pharmacokinetics. Theory and clinical application. Clin Pharmacokinet 1986; 11: 387-401.
96. Holford NHG. MK MODEL Manual. Cambridge, UK: Biosoft, 1994.
97. Anderson BJ, Holford NHG, Woollard GA et al. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol 1998; 46: 237-243.
98. Brown RD, Wilson JT, Kearns GL et al. Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol 1992; 32: 231-241.
99. Mandema JW, Stanski DR. Population pharmacodynamic model for ketorolac analgesia. Clin Pharmacol Ther 1996; 60: 619-635.
100. Boni J, Korth-Bradley J, McGoldrick K et al. Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery. J Clin Pharmacol 1999; 39: 729-737.
101. Day RO, Furst DE, Dromgoole SH et al. Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clin Pharmacol Ther 1982; 31: 733-740.
102. Day RO, Francis H, Vial J et al. Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations. J Rheumatol 1995; 22: 2295-2303.
103. Bertin P, Lapicque F, Payan E et al. Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid. Eur J Clin Pharmacol 1994; 46: 3-7.
104. Suri A, Estes KS, Geisslinger G et al. Pharmacokinetic-pharmacodynamic relationships for analgesics. Int J Clin Pharmacol Ther 1997; 35: 307-323.
105. Anderson B, Anderson M, Hastie B. Paracetamol prescribing habits in a children's hospital. N Z Med J 1996; 109: 376-378.
106. Miner DJ, Kissinger PT. Evidence for the involvement of N-acetyl-p-Quinoneimine in acetaminophen poisoning. Ann Rev Pharmacol Toxicol 1983; 12: 251.
107. Slattery JT, Nelson SD, Thummel KE. The complex interaction between ethanol and acetaminophen. Clin Pharmacol Ther 1996; 60: 241-246.
108. Nahata MC, Powell DA, Durrell DE et al. Acetaminophen accumulation in pediatric patients after repeated therapeutic doses. Eur J Clin Pharmacol 1984; 27: 57-59.
109. Slattery JT, Wilson JM, Kalhorn TF et al. Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans. Clin Pharmacol Ther 1987; 41: 413-418.
110. Kearns GL, Leeder JS, Wasserman GS. Acetaminophen overdose with therapeutic intent. J Pediatr 1998; 132: 5-8.
111. Alonso EM, Sokol RJ, Hart J et al. Fulminant hepatitis associated with centrilobular necrosis in young children. J Pediatr 1995; 127: 888-894.
112. Heubi JE, Bien JP. Acetaminophen use in children: more is not better. J Pediatr 1997; 130: 175-177.
113. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 1998; 132: 22-27.
114. Rivera Penera T, Gugig R, Davis J et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130: 300-304.
115. Hynson JL, South M. Childhood hepatotoxicity with paracetamol doses less than 150 mg/kg per day. Med J Aust 1999; 171: 497.
116. Miles FK, Kamath R, Dorney SFA et al. Accidental paracetamol overdosing and fulminant hepatic failure in children. Med J Aust 1999; 171: 472-475.
117. Morton NS, Arana A. Paracetamol-induced fulminant hepatic failure in a child after 5 days of therapeutic doses. Paed Anaesth 1999; 9: 463-465.
118. Kozer E, Barr J, Bulkowstein M et al. A prospective study of multiple supratherapeutic acetaminophen doses in febrile children. Vet Hum Toxicol 2002; 44: 106-109.
119. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975; 55: 871-876.
120. Prescott LF, Wright N, Roscoe P et al. Plasma paracetamol half-life and hepatic necrosis in patients with paracetamol overdose. Lancet 1971; 1: 519-522.
121. Anderson BJ, Holford NHG, Armishaw JC et al. Predicting concentrations in children presenting with acetaminophen overdose. J Pediatrics 1999; 135: 290-295.
122. Mohler CR, Nordt SP, Williams SR et al. Prospective evaluation of mild to moderate pediatric acetaminophen exposures. Ann Emerg Med 2000; 35: 239-244.
123. Mancini RE, Sonawane BR, Yaffe SJ. Developmental susceptibility to acetaminophen toxicity. Res Commun Chem Pathol Pharmacol 1980; 27: 603-606.
124. Rumack BH. Acetaminophen overdose in children and adolescents. Pediatr Clin North Am 1986; 33: 691-701.
125. Lauterburg BH, Vaishnav Y, Stillwell WG et al. The effects of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis. J Pharmacol Exp Ther 1980; 213: 54-58.
126. Roberts I, Robinson MJ, Mughal MZ et al. Paracetamol metabolites in the neonate following maternal overdose. Br J Clin Pharmacol 1984; 18: 201-206.
127. Levy G, Garrettson LK, Soda DM. Evidence of placenta transfer of acetaminophen. Pediatrics 1975; 55: 895.
128. Lederman S, Fysh WJ, Tredger M et al. Neonatal paracetamol poisoning: treatment by exchange transfusion. Arch Dis Child 1983; 58: 631-633.
129. Kam PC, See AU. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia 2000; 55: 442-449.
130. Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17: 963-976.
131. Lipsky PE, Brooks P, Crofford LJ et al. Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease. Arch Intern Med 2000; 160: 913-920.
132. McCrory CR, Lindahl SG. Cyclooxygenase inhibition for postoperative analgesia. Anesth Analg 2002; 95: 169-176.
133. Brater DC, Harris C, Redfern JS et al. Renal effects of COX-2-selective inhibitors. Am J Nephrol 2001; 21: 1-15.
134. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA 1995; 273: 929-933.
135. Lesko SM, Mitchell AA. Renal function after short-term ibuprofen use in infants and children. Pediatrics 1997; 100: 954-957.
136. Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999; 104: e39.
137. Houck CS, Wilder RT, McDermott JS et al. Safety of intravenous ketorolac therapy in children and cost savings with a unit dosing system. J Pediatr 1996; 129: 292-296.
138. Flato B, Vinje O, Forre O. Toxicity of antirheumatic and anti-inflammatory drugs in children. Clin Rheumatol 1998; 17: 505-510.
139. Szer IS, Goldenstein-Schainberg C, Kurtin PS. Paucity of renal complications associated with nonsteroidal antiinflammatory drugs in children with chronic arthritis. J Pediatr 1991; 119: 815-817.
140. van Biljon G. Reversible renal failure associated with ibuprofen in a child. A case report. S Afr Med J 1989; 76: 34-35.
141. Moghal NE, Hulton SA, Milford DV. Care in the use of ibuprofen as an antipyretic in children. Clin Nephrol 1998; 49: 293-295.
142. Primack WA, Rahman SM, Pullman J. Acute renal failure associated with amoxicillin and ibuprofen in an 11-year-old boy. Pediatr Nephrol 1997; 11: 125-126.
143. Buck ML, Norwood VF. Ketorolac-induced acute renal failure in a previously healthy adolescent. Pediatrics 1996; 98: 294-296.
144. Forrest JB, Heitlinger EL, Revell S. Ketorolac for postoperative pain management in children. Drug Saf 1997; 16: 309-329.
145. Ray PE, Rigolizzo D, Wara DR et al. Naproxen nephrotoxicity in a 2-year-old child. Am J Dis Child 1988; 142: 524-525.
146. Sheiner PA, Mor E, Chodoff L et al. Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. Transplantation 1994; 57: 1132-1133.
147. Kovesi TA, Swartz R, MacDonald N. Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis. N Engl J Med 1998; 338: 65-66.
148. Feldman M, McMahon AT. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med 2000; 132: 134-143.
149. Silverstein FE, Faich G, Goldstein JL et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284: 1247-1255.
150. Bombardier C, Laine L, Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343: 1520-1528.
151. Keenan GF, Giannini EH, Athreya BH. Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis. J Rheumatol 1995; 22: 1149-1151.
152. Dowd JE, Cimaz R, Fink CW. Nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children. Arthritis Rheum 1995; 38: 1225-1231.
153. Mulberg AE, Linz C, Bern E et al. Identification of non-steroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis. J Pediatr 1993; 122: 647-649.
154. Souter AJ, Fredman B, White PF. Controversies in the perioperative use of nonsteroidial antiinflammatory drugs. Anesth Analg 1994; 79: 1178-1190.
155. Rusy LM, Houck CS, Sullivan LJ et al. A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. Anesth Analg 1995; 80: 226-229.
156. Niemi TT, Taxell C, Rosenberg PH. Comparison of the effect of intravenous ketoprofen, ketorolac and diclofenac on platelet function in volunteers. Acta Anaesthesiol Scand 1997; 41: 1353-1358.
157. Niemi TT, Backman JT, Syrjala MT et al. Platelet dysfunction after intravenous ketorolac or propacetamol. Acta Anaesthesiol Scand 2000; 44: 69-74.
158. Bean-Lijewski JD, Hunt RD. Effect of ketorolac on bleeding time and postoperative pain in children: a double-blind, placebo-controlled comparison with meperidine. J Clin Anesth 1996; 8: 25-30.
159. Watcha MF, Jones MB, Lagueruela RG et al. Comparison of ketorolac and morphine as adjuvants during pediatric surgery. Anesthesiology 1992; 76: 368-372.
160. Sutters KA, Shaw BA, Gerardi JA et al. Comparison of morphine patient-controlled analgesia with and without ketorolac for postoperative analgesia in pediatric orthopedic surgery. Am J Orthop 1999; 28: 351-358.
161. Lieh-Lai MW, Kauffman RE, Uy HG et al. A randomized comparison of ketorolac tromethamine and morphine for postoperative analgesia in critically ill children. Crit Care Med 1999; 27: 2786-2791.
162. Splinter WM, Rhine EJ, Roberts DW et al. Preoperative ketorolac increases bleeding after tonsillectomy in children. Can J Anaesth 1996; 43: 560-563.
163. Gallagher JE, Blauth J, Fornadley JA. Perioperative ketorolac tromethamine and postoperative hemorrhage in cases of tonsillectomy and adenoidectomy. Laryngoscope 1995; 105: 606-609.
164. Judkins JH, Dray TG, Hubbell RN. Intraoperative ketorolac and posttonsillectomy bleeding. Arch Otolaryngol Head Neck Surg 1996; 122: 937-940.
165. Agrawal A, Gerson CR, Seligman I et al. Postoperative hemorrhage after tonsillectomy: use of ketorolac tromethamine. Otolaryngol Head Neck Surg 1999; 120: 335-339.
166. Romsing J, Ostergaard D, Walther-Larsen S et al. Analgesic efficacy and safety of preoperative versus postoperative ketorolac in paediatric tonsillectomy. Acta Anaesthesiol Scand 1998; 42: 770-775.
167. Strom BL, Berlin JA, Kinman JL et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A post-marketing surveillance study. JAMA 1996; 275: 376-382.
168. -1 i.v. in small children during adenoidectomy. Br J Anaesth 1997; 79: 606-608.
169. Nikanne E, Kokki H, Tuovinen K. IV perioperative ketoprofen in small children during adenoidectomy. Br J Anaesth 1997; 78: 24-27.
170. Kokki H, Nikanne E, Tuovinen K. I.v. intraoperative ketoprofen in small children during adenoidectomy: a dose-finding study. Br J Anaesth 1998; 81: 870-874.
171. Thiagarajan J, Bates S, Hitchcock M et al. Blood loss following tonsillectomy in children. A blind comparison of didofenac and papaveretum. Anaesthesia 1993; 48: 132-135.
172. Walmsley AJ. Peri-operative use of nonsteroidal anti-inflammatory drugs in children. Anaesthesia 1997; 52: 1120.
173. Romsing J, Ostergaard D, Drozdziewicz D et al. Diclofenac or acetaminophen for analgesia in paediatric tonsillectomy outpatients. Acta Anaesthesiol Scand 2000; 44: 291-295.
174. Harley EH, Dattolo RA. Ibuprofen for tonsillectomy pain in children: efficacy and complications. Otolaryngol Head Neck Surg 1998; 119: 492-496.
175. St Charles CS, Matt BH, Hamilton MM et al. A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy patient. Otolaryngol Head Neck Surg 1997; 117: 76-82.
176. Holford NHG. The target concentration approach to clinical drug development. Clin Pharmacokinet 1995; 29: 287-291.
177. Holford NHG. Target concentration intervention: beyond Y2K. Brit J Clin Pharmacol 1999; 48: 9-13.
178. van Lingen RA, Simons SH, Anderson BJ et al. The effects of analgesia in the vulnerable infant during the perinatal period. Clin Perinatol 2002; 29: 511-534.
179. Berger RG. Intelligent use of NSAIDs - where do we stand? Expert Opin Pharmacother 2001; 2: 19-30.
180. Jackson LM, Hawkey CJ. COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages? Drugs 2000; 59: 1207-1216.